Why I'm Putting 100x Bleach on My Face

Justin Gardner, who spent 20 years developing hospital products, explains that when skin breaks, white blood cells rush to the site and release HOCl to fight infection and trigger repair. Applying it topically mimics that internal response. Unlike hydrogen peroxide, which oxidizes everything—including fibroblasts and growth factors—HOCl is selective. It also addresses biofilm‑protected bacteria by disrupting the extracellular matrix that shields them. For chronic conditions like eczema, HOCl selectively targets Staphylococcus aureus that colonizes flares, helping rebuild the skin’s healthy microbiome. Dave notes that he used it on his tattoo blister, and Justin emphasizes that the same medical‑grade formulation is used in operating rooms, so the home user gets equivalent performance.

Dave, an early adopter of red‑light therapy, asks whether Active Skin Repair can stand alone or should be stacked. Justin confirms that HOCl by itself speeds healing, and then the addition of red/infrared light “can stack really nicely because those are well documented to speed healing.” Dave built a renowned post‑surgical recovery protocol that (without HOCl) doubled his foot‑surgery healing speed; adding HOCl would be the logical next iteration. The conversation positions this as a practical, multi‑modal biohack that leverages both chemical and photonic interventions to compress recovery time.

Dave shares that he suffered from rosacea in his late teens/early 20s and it resolved when he reduced systemic inflammation. He notes that ivermectin cream is having “incredible results” and speculates that this is not because of “evil little worms” but due to other pathways. Justin agrees that complex chronic conditions need multi‑modal approaches and that HOCl fits into such protocols because it is safe, non‑irritating, and targets the microbial component without steroids. Dave suggests using ivermectin as the systemic/long‑term layer and HOCl as the rapid‑response layer.

Dave walks through his exact query sequence: first a neutral prompt, then one that forces the AI to role‑play as a functional medicine biohacker. He notes that the two answers differ substantially, with the second providing deeper mechanistic pathways and PubMed references. Justin adds that this approach has uncovered articles on hypochlorous acid that his own R&D team hadn’t seen. Dave also advocates using AI to parse thousands of Amazon reviews, effectively creating a rapid meta‑analysis of user experiences. He posits that an AI‑powered physician—one who combines clinical experience with real‑time AI querying—will be the future of medicine.

Though the official indication is topical, the conversation openly speculates about oral use. Justin notes that people already use it in sinuses and on biofilms, and that in hospitals it is used to disrupt biofilm in chronic wounds. Dave explicitly ties this to dental caries: “cavities are biofilms.” He underscores the regulatory absurdity: a company cannot claim it stops cavities without a $100M trial. He encourages listeners to search PubMed, noting that the mechanism supports it. Dave says he would personally use it on inflamed gums.

Justin explains that in chronic skin conditions, the skin’s microbiome is disrupted and staph often colonizes the lesions, stalling healing. By applying HOCl first, you clear that bacterial burden and reduce inflammation without introducing steroids or antibiotics. He highlights pediatric use, including diaper rash, where parents can spray HOCl and then apply a barrier cream. Dave connects this to the broader biohacking shift away from indiscriminate antimicrobials toward microbiome‑sparing interventions.

Dave’s bicep tattoo, which features a caffeine molecule, was blistered by an acid‑forming beetle during an Amazon retreat. While he had previously used biohacking stacks for surgical recovery, he had not yet tried hypochlorous acid (HOCl). Guest Justin Gardner explains that HOCl is the same molecule produced by neutrophils during the oxidative burst; it works as an antimicrobial, an anti‑inflammatory, and a healing accelerator. Dave contrasts this with Neosporin, which merely sits in petroleum jelly with no pro‑healing effect, and with hydrogen peroxide, which “nukes” the wound including the good cells. Because HOCl is selective—it breaches bacterial cell membranes at multiple points but spares human cells—it avoids antibiotic resistance and microbiome damage. The product available over‑the‑counter uses the exact medical‑grade formulation found in operating rooms, so the listener is getting hospital‑grade care at home.

Dave recounts that after returning from the Amazon, stem‑cell clinic physicians couldn’t identify the blister. He first tried ChatGPT but found it had become “dumb,” so he turned to Claude, supplying the geographic region and a photo. Claude listed the standard medical differentials and then concluded an acid‑forming beetle was the likely cause—matching his experience. From there, Dave began using AI to evaluate HOCl: “I’m looking at using Active Skin Repair and HOCL… Give me a take on that,” then prompt a second time as “a functional medicine practitioner, biohacker, and expert in physiology.” The two answers differed dramatically, and the second provided mechanistic pathways and citations. Dave also suggests using AI to mine Amazon reviews, turning thousands of user experiences into evidence. He calls out Google’s AI as anti‑alternative medicine and names Claude, Grok, and Perplexity as the top picks for health research. Justin adds that AI can surface PubMed articles even he as a manufacturer hadn’t seen.

Justin explains that hypochlorous acid is notoriously finicky: it must be packaged in a specific bottle–liquid ratio, held at a narrow pH window, and cannot be combined with fragrances or other additives. Even switching to a 1 oz bottle would disrupt the plastic‑to‑liquid balance and kill shelf life. His team has spent two years just stability‑testing bottle changes. When they test competitors’ products that mix HOCl with other ingredients, “there is no active hypochlorous in these bottles.” Others may start with the right pH and ppm, but within three to four months the pH drops and the HOCl degrades, making the product potentially irritating. Dave draws a parallel to the MCT oil market: when Onnit sold cheap MCT forms that caused digestive distress and no cognitive benefit, consumers concluded MCT didn’t work, hurting the entire category. He stresses that integrity in formulation is a fiduciary duty to the user.

Dave describes a company whose device was approved for wrinkles but in research prevented heart transplants—yet they couldn’t talk about it. He frames the system as one that blocks progress. For HOCl, the mechanism of biofilm disruption is well documented: HOCl penetrates the biofilm matrix and kills the planktonic bacteria within. When he suggests swishing it in the mouth, Justin confirms people do it but the product is only FDA‑cleared for topical use. Dave states he would personally smear it on inflamed gums, and he explicitly tells listeners to search PubMed for hypochlorous acid, implying that the research supports broader application. He also mentions that cavities are a biofilm disease, so HOCl has a theoretical role in oral care, though he cannot make that claim without a $100 million trial.